The present studies compared the acute effects of benztropine analogs (4-Cl-BZT, JHW 007, AHN 1-055), which are atypical dopamine uptake inhibitors, with those of the standard dopamine uptake inhibitors GBR 12909 and cocaine, on the reinforcing efficacy of food and food intake in male Sprague-Dawley rats. Repeated drug effects of JHW 007 on food intake were also determined. The number of ratios completed under a progressive-ratio schedule of food delivery was used as an index of reinforcing efficacy. Food intake was determined by measuring powdered laboratorychow consumption during daily 40 min food-availability time periods. Under the progressive-ratio schedule, cocaine and GBR 12909 dose-dependently increased the number of ratios completed. JHW 007 decreased ratios completed, whereas neither 4-Cl-BZT nor AHN 1-055 increased ratios completed with a magnitude that approximated any of the increases produced by cocaine or GBR 12909. Acute administration of each drug dose-dependently decreased food intake; however, the benztropine analogs were more potent than cocaine and GBR 12909. A reduction in food intake emerged after repeated administration of a low dose of JHW 007. Future studies that compare JHW 007 with standard anorectic drugs (e.g. phentermine) and continue investigation of the repeated drug effects under similar experimental procedures are clearly warranted. Behavioural Pharmacology 28:74-82
Introduction
Previous studies have suggested that novel atypical dopamine (DA) uptake inhibitors, such as analogs of benztropine (BZT) that have a high affinity and selectivity for the DA transporter, paradoxically have low abuse potential of their own and have potential for the treatment of stimulant abuse [see the review by Tanda et al. (2009a) ]. For example, BZT analogs are less effective than cocaine in stimulating locomotor activity, producing cocaine-like discriminativestimulus effects, and in stimulating DA release in brain regions associated with reinforcement in rats [see the review by Tanda et al. (2009a) ]. In addition, BZT analogs are either less effective than cocaine in maintaining self-administration behavior (AHN 1-055) or are not self-administered (JHW 007, AHN 2-005), and pretreatment with these compounds decreases cocaine self-administration (Ferragud et al., 2009; Hiranita et al., 2009) and can attenuate neurochemical effects of cocaine (Tanda et al., 2009b) . A similar profile of behavioral and pharmacological effects of BZT analogs has been found with other psychostimulant drugs of abuse such as amphetamine and methamphetamine (Velazquez-Sanchez et al., 2011 , 2013 Ferragud et al., 2014) .
The current study was a continued investigation into the similarities and differences among the effects of typical and atypical DA uptake inhibitors -particularly effects related to food reinforcement. Hiranita et al. (2009) examined the effects of three BZT analogs (AHN 1-055, AHN 2-005, and JHW 007) under an FR 5 schedule of food reinforcement. Orally administered doses (10-100 mg/kg) of the latter two drugs did not appreciably alter response rates; however, a number of unique experimental manipulations were conducted to facilitate matching of baseline response rates to the rate of cocaine self-administration (e.g. subjects were given their daily ration of food 60 min before treatment with the BZT analogs). Ferragud et al. (2014) found that the BZT analog JHW 007 (3 and 10 mg/kg) also did not appreciably alter responding maintained under an FR 3 schedule of sucrose delivery. The primary aim of the present study was to evaluate and compare the effects of several BZT analogs (AHN 1-055, JHW 007, 4-Cl-BZT) with standard indirect monoaminergic agonists (cocaine and the more DA selective agent GBR 12909) on different assessments of food reinforcement -specifically procedures that are commonly used to assess appetitesuppressant effects of drugs that may provide indications for an antiobesity medication (LeSage et al., 2004) .
In experiment 1, we determined the effects of the abovementioned compounds on behavior reinforced with food under a progressive-ratio (PR) schedule of food delivery. A typical PR schedule is one in which the number of responses required to obtain food increases progressively after each food presentation. The highest ratio completed before lever pressing ceases within a defined time period (commonly referred to as a break point) is considered an index of the efficacy of food as a reinforcer (Hodos, 1961; Hodos and Kalman, 1963) . However, it is also important to note that drugs can have multiple behavioral effects and thus changes in performance under a PR schedule may be attributed to effects other than changes in reinforcer efficacy [e.g. changes in general activity or stereotypy, cf. Jones et al. (1995) ; Lesage et al. (2004) ]. There is one previous study (Ferragud et al., 2014) that examined the effects of one BZT analog (JHW 007, 3, and 10 mg/kg) under a PR schedule of sucrose delivery and found that JHW 007 dose-dependently increased the number of ratios completed, suggesting an increase in the reinforcing efficacy of the sucrose solution.
Another common procedure used to assess the appetitesuppressant effects of drugs is to examine food consumption during limited access periods. In experiment 2, we assessed the acute effects of the above-mentioned typical and atypical DA uptake inhibitors on food consumption during a 40 min daily-feeding period in fooddeprived rats. Findings from the first two experiments indicated prominent effects consistent with appetite suppression for the BZT analog JHW 007. Therefore, a third experiment was conducted to determine the effects of chronic administration of JHW 007 (as anorectic drugs are typically taken repeatedly), at doses that produced minimal behavioral effects, to assess potential for appetite suppression without toxicity.
Methods

Subjects
The subjects were male Sprague-Dawley rats, weighing 325-350 g (Taconic Farms, Hudson, New York, USA) in experiment 1 (n = 5) and 250-300 g (Charles River Laboratories Inc., Wilmington, Massachusetts, USA) in experiments 2 (n = 8) and 3 (n = 24). They were housed individually in a temperature-controlled and humiditycontrolled vivarium under a 12-h light/dark cycle (lights on 07:00 h), and had unlimited access to water. In experiment 1, animals were fed ∼ 10-15 g of standard Purina rat chow (Purina Mills Inc., St Louis, Missouri, USA) 1 h after each session; thus, each subject was food restricted for ∼ 22 h before the start of each experimental session. In experiments 2 and 3, animals were fed a daily ration of ∼ 20 g of standard Purina rat chow until 2 weeks before testing. Care of the subjects was in accordance with the guidelines of the National Institutes of Health and the National Institute on Drug Abuse Intramural Research Program Animal Care and Use Program.
Apparatus
In experiment 1, experimental sessions were conducted in two-lever operant conditioning chambers (modified ENV 007; Med Associates Inc., St Albans, Vermont, USA) that were enclosed in ventilated, sound-attenuating cubicles and provided with white noise at all times to mask extraneous sounds (ENV-018; Med Associates Inc.). The front panel of the operant chambers consisted of the two responses levers, which were 10.2 cm apart, two pairs (one red and one green) of light-emitting diodes (LEDs) and house-lights, located directly above each response lever, and a food receptacle behind an ∼ 5 × 5 cm opening centered between the two levers. Each lever press on either lever with a downward force of ∼ 0.4 N through ∼ 1 mm produced an audible click and was recorded as a response. A food pellet dispenser (ENV-203; Med Associates Inc.) behind the front panel delivered 45 mg food pellets (BioServ Inc., Frenchtown, New Jersey, USA) into the receptacle. Experimental variables and data collection were controlled and recorded with desk-top computers, commercially available interfacing equipment, and operating software (Med Associates Inc.).
In experiments 2 and 3, subjects were tested in plastic cages that were identical to the home cage (30 × 19 × 19 cm). Powdered food (100 g) was presented to each subject in feeding jars with a diameter of 8.5 cm and a height of 4.5 cm. A lid with a centered circular (diameter 3.3 cm) aperture limited spillage.
Experiment 1: acute drug effects under a progressiveratio schedule of food delivery Subjects were initially trained to press a lever under a fixed-ratio 1 (FR 1) schedule of food reinforcement. Assignment of right or left levers was counterbalanced across subjects. After a 5-min time-out period, the houselight and each pair of red and green LEDs above the active lever were illuminated. A single active lever press turned off the LEDs, produced a 0.1 s flash of the houselight, and delivered a single food pellet. A 10-s time-out period followed each pellet delivery, during which all lights inside the chamber were off and responses had no programmed consequences. Sessions lasted until 40 food pellets were presented.
The number of responses required for each pellet delivery was gradually increased across 10 sessions from FR 1 to FR 10. Approximately 15 training sessions were then performed under an FR 10 schedule of food reinforcement, after which a PR schedule was followed for the rest of the study. Under this schedule, the number of required responses was two for the first ratio of the session and incremented exponentially after each pellet delivery such that the sequence was as follows: 2, 4, 7, 11, 17, 25, 36, 50, 69, 95, 131, 178, 242, 328, 445, 603, 815, 1102, and 1489 . Experimental sessions terminated after 2 h or if responding on the active lever ceased for 15 min. The last FR completed before session termination because of a 15 min pause in active lever pressing was defined as the 'break point.'
Drug testing was initiated after ∼ 25 sessions under the PR schedule. Drug tests were generally performed on Tuesdays and Fridays, with vehicle test sessions interposed between drug test days on Thursday. Drugs were tested in the following order, with the indicated pretreatment times and with cocaine tested once at the beginning and once at the end of the study: cocaine (5 min), GBR 12909 (5 min), JHW 007 (5 min), AHN 1-055 (10 min), 4-Cl-BZT (10 min), and cocaine (5 min). Individual doses of each drug were administered in a mixed sequence.
Experiment 2: acute drug effects on feeding behavior Two weeks before testing, all subjects were provided daily access to 100 g of powdered Bio-Serv diet (BioServ Inc.) for 40 min on weekdays and 20 g of standard laboratory chow on weekends. This feeding routine was followed for the rest of the experiment. Testing was performed in a room separate from the colony room. Before test sessions, all rats were weighed and doses of each drug were administered only if the group mean body weight deviated less than 10% from the initial body weight. Test sessions were generally performed on Tuesdays and Fridays, with vehicle test sessions interposed between drug test days on Mondays and Thursdays; no injections were administered on Wednesdays. On test days, all rats received an injection of a dose of a test drug 10 min before the filled and preweighed feeding jars were placed inside the test cages. After 40 min, the jars were removed from the test cages and weighed. Food intake was calculated by subtracting postfeeding values from prefeeding values. Drugs were tested in the following order with individual doses in a mixed sequence: cocaine, GBR 12909, 4-Cl-BZT, JHW 007, and AHN 1-055.
Experiment 3: repeated drug effects of JHW 007 on feeding behavior
Before repeated drug testing, subjects were provided daily access to 100 g of powdered Bio-Serv diet (BioServ Inc.) for 40 (2.37 µmol/kg group) or 60 min (7.11 µmol/kg group) on weekdays (see below for rationale in food access duration change) and 20 g of standard laboratory chow on weekends. Repeated drug testing was initiated after approximately six daily-feeding sessions in which there were no trends in the average amount of food consumed for each subject. Food consumption was measured and calculated as in experiment 2. Once repeated drug testing was initiated, daily access to 100 g of powdered Bio-Serv diet continued 7 days per week for a maximum of 17 consecutive days. In a betweensubjects design, 2.37 µmol/kg JHW 007 (10 min pretreatment) was tested in 6 subjects while a separate group of subjects (n = 6) received repeated saline injections.
Following testing of 2.37 µmol/kg JHW 007, a new group of subjects (n = 6) were tested with 7.11 µmol/kg JHW 007 (10 min pretreatment) while a separate group of subjects (n = 6) received repeated saline injections. The duration of food access was increased for the 7.11 µmol/kg group because the vehicle-control group that was compared with the 2.37 µmol/kg JHW 007 group had lost weight during repeated testing (as shown in the Results section).
Drugs
Cocaine hydrochloride and GBR 12909 were obtained from Sigma-Aldrich (St Louis, Missouri, USA). The BZT analogs, 4′-chloro-3α(diphenylmethoxy)-tropane (4-Cl-BZT), 3α-[bis-(4-fluorophenyl)methoxy]tropane (AHN 1-055), and N-(n-butyl)-3α-[bis(4′-fluorophenyl)methoxy]-tropane (JHW 007) were synthesized in the Medicinal Chemistry Section (Intramural Research Program, National Institute on Drug Abuse, Baltimore, Maryland, USA) according to published procedures (Newman et al., 1994; Agoston et al., 1997) . All drugs were dissolved in sterile water or 0.9% saline (NaCl), and were injected intraperitoneally at 1 ml/kg body weight. For complete solubilization, GBR 12909 and BZT analogs were sonicated and heated. Doses of each drug are expressed in terms of the salt.
Data analysis Experiment 1
Response rates and number of ratios completed were the dependent measures. The number of completed ratios directly corresponds to the log transformation of the final ratio value obtained (Richardson and Roberts, 1996) . The two determinations of cocaine were analyzed using a twoway repeated-measures analysis of variance (ANOVA) (within-subjects factors: time and drug dose). One-way repeated-measures ANOVA was used to analyze the effects of GBR 12909, AHN 1-055, JHW 007, and 4-Cl-BZT (within-subjects factor: drug dose), with these results detailed in the figure captions. Multiplecomparison tests were performed using Bonferroni corrections. Data from the linear portions of the dose-effect curves for ratios completed were used to calculate an ED 25 value (i.e. the dose that produced a 25% change from the number of ratios completed under vehicle-control conditions) and their 95% confidence limits (CLs). Significant differences for all analyses were based on P value less than 0.05.
Experiment 2
The mean amount of food consumed (g) was the dependent measure. Each dose-effect curve for each drug was analyzed using standard ANOVA and linear regression techniques. Data from the linear portions of the dose-effect curves were used to calculate ED 50 values and their 95% CLs (Snedecor and Cochran, 1967) ; where appropriate, one-way ANOVAs and Dunnett's t-tests were performed. A significant difference in the ED 50 values is indicated by 95% CLs that do not overlap. Significant differences for all analyses were based on P value less than 0.05.
Experiment 3
The average body weight (g) and amount of food consumed (g) were the dependent measures. Each measure was analyzed with a two-way repeated measures ANOVA at each dose with a between-subjects factor of group (JHW 007 or saline) and a within-subjects factor of session. Multiple-comparison tests were performed using Holm-Sidak comparisons. Significant differences for all analyses were based on P value less than 0.05.
Results
Experiment 1: acute drug effects under a progressiveratio schedule of food delivery Both cocaine and GBR 12909 generally increased response rates in a dose-dependent manner under the PR schedule (Fig. 1a) , although the ANOVA showed only a significant main effect of dose for cocaine, indicating significant increases at the highest two doses. The BZT analogs produced a range of effects on response rates. AHN 1-055 (Fig. 1c) , similar to cocaine, significantly increased rates of responding, with the highest dose producing effects significantly different from vehicle. In contrast, 4-Cl-BZT (Fig. 1b) and JHW 007 (Fig. 1d) produced only dose-dependent and significant decreases in response rates. The multiple comparisons showed that the highest dose of 4-Cl-BZT and the two highest doses of JHW 007 significantly decreased response rates.
Similar to the effects on the response rate, both cocaine and GBR 12909 produced dose-dependent increases in the number of ratios completed under the PR schedule (Fig. 2a) . The main effect of dose was significant for each drug and multiple-comparison analyses showed significant effects as indicated in the figures compared with vehicle-control values. These dose-dependent increases in ratios completed for cocaine and GBR 12909 were accompanied by dose-dependent decreases in the number of sessions that ended because of the 'break point' criterion (Table 1) .
In contrast to the effects of cocaine and GBR 12909, the BZT analogs were considerably less effective in increasing the number of ratios completed in a session (Fig. 2) . 4-Cl-BZT produced a significant increase in the number of ratios completed at a dose of 44.94 µmol/kg; however, this increase (∼2 ratios on average) was less than that obtained with cocaine and GBR 12909, and was not obtained at higher doses (Fig. 2b ). There were no significant effects of AHN 1-055 on the number of ratios completed (Fig. 2c) , although there was a trend toward an increase at the highest dose studied. In contrast, JHW 007 ( Fig. 2d) significantly decreased the number of ratios completed at a dose of 23.70 µmol/kg. Furthermore, unlike cocaine and GBR 12909, test sessions generally terminated because of fulfillment of the 'break point' criterion, even as the dose of each BZT analog increased (Table 1) . The potency analysis (Table 2) indicates that the BZT analogs AHN 1-055 and 4-Cl-BZT were generally less potent in increasing the number of ratios completed than cocaine and GBR 12909. For all drugs, earned food pellets were consumed during the experimental sessions.
Experiment 2: acute drug effects on feeding behavior
Acute administration of all of the drugs studied decreased food intake in a dose-dependent manner, with maximum decreases in food intake produced by the highest doses of each drug (Fig. 3) . Over the domain of doses examined, all drugs appeared to be in the same range of effectiveness (Fig. 3) . The ANOVAs confirmed significant effects of cocaine, GBR 12909, 4-Cl-BZT, AHN 1-055, and JHW 007 with significant reductions in food intake compared with the control values, as indicated in the figure. The ED 50 values (Table 2) confirm that the BZT analogs were generally more potent in reducing food intake compared with both cocaine and GBR 12909. In addition, the potencies of cocaine and GBR 12909 for decreasing food intake were greater than their potencies for increasing the number of ratios completed under the PR schedule. In contrast, the potencies of the BZT analogs for affecting performance under the PR schedule were generally comparable with their potencies for decreasing food intake.
Across 17 daily sessions of repeated dosing with 2.37 µmol/kg JHW 007 ( Fig. 4a and c) , both the average weight (before eating) of the subjects and the amount of food consumed were not different from the vehicle group. The weights of subjects treated with 7.11 µmol/kg JHW 007 (Fig. 4b) showed a decreasing trend, whereas those of subjects treated with vehicle showed an increasing trend. The ANOVA resulted in a significant interaction, with tests corrected for multiple comparisons showing significantly lower weights for the 7.11 µmol/kg group across sessions 11 through 17. As can be seen in Fig. 4d , food intake also increased across sessions for the vehicle group, whereas food intake remained unchanged and relatively lower for the 7.11 µmol/kg JHW 007 group. The ANOVA did not result in a significant interaction; however, tests corrected for multiple comparisons showed differences between groups for sessions 13 through 16. One subject in the 7.11 µmol/kg JHW 007 group died before testing on day 17; this subject showed the largest change in weight and its exclusion from the group led to the small increase in the group average for body weight and food consumed on session 17.
Discussion
The performances under the PR schedule are consistent with a number of previous studies that have reported that BZT analogs generally do not share all of the pharmacological and behavioral effects with cocaine, despite having a high affinity and selectivity for the DA transporter (Ferragud et al., 2009; Tanda et al., 2009a) . In the present study, cocaine significantly increased response rates under the PR schedule, whereas GBR 12909 produced a dose-dependent trend for increased response rates. However, neither 4-Cl-BZT nor JHW 007 increased response rates under the PR schedule, and only the highest dose of AHN 1-055 increased response rate to a degree approaching that for cocaine. Among BZT analogs, AHN 1-055 often produces the most 'cocaine-like behavioral effects' [e.g. in the amount of substitution for cocaine in a drug-discrimination procedure, the extent of increased locomotion, or in the degree of self-administration; see Tanda et al. (2009a) ].
Administration of cocaine and GBR 12909 was found to significantly increase the number of ratios completed under a PR schedule of food delivery. A similar finding has been described in other studies with intermediate doses of cocaine (Thompson, 1977; Poncelet et al., 1983; Jones et al., 1995; Sizemore et al., 2003) and other psychostimulants such as D-amphetamine and methylphenidate (Schulze and Paule, 1990; Mayorga et al., 2000) . This effect appears to be at odds with the interpretation that performance under a PR schedule is a pure indication of reinforcer efficacy as both drugs decreased food intake. It is not unheard of for multiple measures of behavioral constructs to be altered by independent variables in different manners [e.g. Brito (1985) ]. As drugs generally have multiple effects, it is likely that the behavioral stimulant effect of cocaine and GBR 12909 under the PR schedule is distinct from any actions resulting in a decrease in the reinforcing effects of food. Similarly, LeSage et al. (2004) found that administration of the stimulant phentermine at intermediate doses decreased food intake in some subjects under free-feeding conditions, but increased ratios completed under a PR schedule of food delivery.
In contrast to the effects of cocaine and GBR 12909 on the number of ratios completed, the BZT analogs produced a distinct profile of effects. The BZT analog JHW 007 decreased ratios completed, whereas 4-Cl-BZT and AHN 1-055 did not increase the number of ratios completed to the extent of cocaine and GBR 12909. Further, the comparisons of dose-dependent effects indicated that the BZT analogs 4-Cl-BZT and AHN 1-055 were generally less potent and less efficacious in increasing ratios completed under the PR schedule than were cocaine and GBR 12909 -thus indicating further delineation between typical and atypical DA uptake inhibitors. The decrease in ratios completed following JHW 007 administration is in apparent conflict with a previous report (Ferragud et al., 2014) that JHW 007 dose dependently increased reinforcers earned under a PR schedule of sucrose delivery. Reconciliation of the discrepant findings could be directed at rat strain comparison (hooded PVG vs. Sprague-Dawley rats) or within-subject analyses of pretreatment times (60 vs. 5 min), food type (100 µl of 10% 7.11 μmol/kg Vehicle * * * * Session Food Consumed (g) (a-d) Effects of 2.37 (filled triangle) and 7.11 (filled circle), µmol/kg JHW 007, and vehicle (open symbols) on body weight (upper row) and food intake (lower row) in rats provided access to powdered laboratory chow over a daily period of 40 (2.37 µmol/kg) or 60 min (7.11 µmol/kg) during repeated drug treatments. Vertical axes: mean starting weight in grams (top row) and mean food intake in grams (bottom row). Horizontal axes: average body weight during baseline sessions before drug treatment and the number of repeated drug or vehicle sessions. Each data point represents an average ( SEM) effect determined for five to six subjects. The analysis of variance indicated a significant interaction for starting weight at the 7.11 µmol/kg dose (F 16,159 = 2.56; P < 0.05). Holm-Sidak multiple-comparison tests indicated significant reductions in starting weight compared with the vehicle group across sessions 11 through 17. Although the analysis of variance was not significant (F 16, 159 = 1.33; P > 0.05) for the amount of food consumed at 7.11 µmol/kg, Holm-Sidak multiple-comparison tests indicated significant reductions in food consumed relative to the vehicle group across sessions 11 through 16. Statistically significant effects are denoted by an asterisk.
sucrose administered in five drops vs. 45 mg food pellets), or break point criterion [1 h since last active lever response vs. 15 min; cf. Stafford and Branch (1998) 
Consistent with previous studies (van Rossum and Simons, 1969; Balopole et al., 1979; Cooper and van der Hoek, 1993; van der Hoek and Cooper, 1994) , the indirect DA agonist cocaine and the selective DA uptake inhibitor GBR 12909 decreased food intake in a doserelated manner during acute drug testing. Administration of the BZT analogs 4-Cl-BZT, JHW 007, and AHN 1-055 also dose dependently decreased food intake. The rank order of potency for decreasing food intake, on the basis of ED 50 values, was 4-Cl-BZT > AHN 1-055≈JHW 007 > GBR 12909≈cocaine. On the basis of their high and selective in-vitro binding affinities for the DA transporter [e.g. Katz et al. (1999 Katz et al. ( , 2004 ], these findings suggest that, similar to cocaine and GBR 12909, BZT analogs also produced reductions in food intake primarily through actions at the DA transporter, but with greater potency.
As acute administration of JHW 007 showed the most consistent profile for appetite-suppressant effects under the PR schedule and during food intake testing, we further examined its effects during repeated treatment with a focus on doses producing minimal acute behavioral effects to assess the development of appetite suppression without toxicity. Repeated administration of 7.11 µmol/ kg JHW 007 resulted in statistically significant reductions in body weight and food intake that emerged after ∼ 11-13 consecutive days of drug exposure. Repeated administration at one third the dose (2.37 µmol/kg) showed no indication of changes relative to the control group in weight or food consumed. However, both groups (vehicle and 2.37 µmol/kg) were losing weight throughout the study, likely because the duration of food access was shorter than that in the subsequent study at the higher dose, in which control subjects gained weight. Future studies should begin to investigate the potential development of tolerance to the reduction in feeding behavior produced by JHW 007, which is a finding typical of CNS anorectic drugs (Choi et al. 2002; Wellman et al. 2003; Fernstrom and Choi, 2008) , by comparing dose-effect curves before and after a repeated drug regimen.
Several researchers have suggested that the DArgic mechanisms involved in the abuse of psychomotor stimulant drugs are similar to those involved in feeding behavior and food reinforcement (Hernandez and Hoebel, 1988; Clifton and Kennett, 2006) , although there are other pharmacological targets of interest (Bray, Greenway, 2007; Palmiter, 2007) . Findings from the current study support further exploration of BZT analogs as appetite suppressants -in particular, JHW 007. Future studies that compare JHW 007 with standard anorectic drugs (e.g. phentermine) and continue investigation of the repeated drug effects under similar experimental procedures are clearly warranted.
